Dezhan Healthcare Hits Day Low at CNY 3.25 Amid Price Pressure

Dezhan Healthcare Co., Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant decline today, with its stock price dropping by 6.03%. The stock reached an intraday low of CNY 3.25, reflecting ongoing challenges faced by the company. Over the past week, Dezhan Healthcare's performance has been similarly negative, with a decrease of 6.84%. In the longer term, the company has struggled, showing a year-to-date decline of 14.84% and a substantial 19.26% drop over the past year. The stock's performance over the last five years has been particularly concerning, with a decrease of 26.19%, and a staggering 77.85% decline over the past decade. Financial metrics indicate a low Return on Capital Employed (ROCE) of 1.63%, highlighting profitability issues. The company has reported negative results for seven consecutive quarters, with net sales falling by 25.72%. These factors contribute to a challenging market position for Dezhan Healthcare, as it continues to navigate a difficult financial landscape.